Submission Details
| 510(k) Number | K063845 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 27, 2006 |
| Decision Date | December 07, 2007 |
| Days to Decision | 345 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K063845 is an FDA 510(k) clearance for the ADVIA CHEMISTRY TOTAL BILIRUBIN_2, a Enzymatic Method, Bilirubin (Class II — Special Controls, product code JFM), submitted by Bayer Healthcare, LLC (Tarrytown, US). The FDA issued a Cleared decision on December 7, 2007, 345 days after receiving the submission on December 27, 2006. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1110.
| 510(k) Number | K063845 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 27, 2006 |
| Decision Date | December 07, 2007 |
| Days to Decision | 345 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | JFM — Enzymatic Method, Bilirubin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1110 |